These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32695641)

  • 1. The use of cardiovascular magnetic resonance as an early non-invasive biomarker for cardiotoxicity in cardio-oncology.
    Burrage MK; Ferreira VM
    Cardiovasc Diagn Ther; 2020 Jun; 10(3):610-624. PubMed ID: 32695641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cardiovascular magnetic resonance imaging in cardio-oncology.
    Saunderson CED; Plein S; Manisty CH
    Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):383-396. PubMed ID: 33404058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
    Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
    Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
    Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
    Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Imaging in Cardio-Oncology.
    Avelar E; Strickland CR; Rosito G
    Curr Treat Options Cardiovasc Med; 2017 Jun; 19(6):46. PubMed ID: 28474324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
    Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
    Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Magnetic Resonance Imaging in Oncology.
    Jeong D; Patel A; Francois CJ; Gage KL; Fradley MG
    Cancer Control; 2017 Apr; 24(2):147-160. PubMed ID: 28441369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians.
    Johnson CB; Sulpher J; Stadnick E
    Curr Opin Cardiol; 2015 Mar; 30(2):197-204. PubMed ID: 25574894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics.
    Parashar A; Hundley WG
    Curr Cardiol Rep; 2018 Oct; 20(12):142. PubMed ID: 30367282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.
    Khouri MG; Klein MR; Velazquez EJ; Jones LW
    Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cardiovascular MRI in Cardio-Oncology.
    Bottinor W; Trankle CR; Hundley WG
    Heart Fail Clin; 2021 Jan; 17(1):121-133. PubMed ID: 33220881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: From Early Detection to Unravelling Mechanisms of Cardiotoxicity.
    Leo I; Vidula M; Bisaccia G; Procopio MC; Licordari R; Perotto M; La Vecchia G; Miaris N; Bravo PE; Bucciarelli-Ducci C
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardio-oncology: A Focus on Cardiotoxicity.
    Koutsoukis A; Ntalianis A; Repasos E; Kastritis E; Dimopoulos MA; Paraskevaidis I
    Eur Cardiol; 2018 Aug; 13(1):64-69. PubMed ID: 30310475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Magnetic Resonance Imaging in the Early Detection of Cardiotoxicity Induced by Cancer Therapies.
    Wei X; Lin L; Zhang G; Zhou X
    Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 36010197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges.
    Park CJ; Branch ME; Vasu S; Meléndez GC
    J Cardiovasc Transl Res; 2020 Jun; 13(3):367-376. PubMed ID: 32248349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
    Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
    Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.